Moderna Inc
(XKAZ:MRNA_KZ)
$
94
0 (0%)
Market Cap: 15.50 Bil
Enterprise Value: 9.98 Bil
PE Ratio: 0
PB Ratio: 1.30
GF Score: 62/100 Moderna Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021 / 09:30PM GMT
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
All right. Good afternoon, everyone, from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Moderna, and CEO Stéphane Bancel. Please note that following this presentation, we will have a Q&A session right here. (Operator Instructions)
So with that, Stéphane, thank you so much for being here today. Look -- very much looking forward to this presentation and discussion. With that, let me turn things over to you.
StÃ;phane Bancel
Moderna, Inc. - CEO & Director
© -
Thank you, Cory, and good afternoon, everybody. Can you see my screen, Cory?
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
Yes.
StÃ;phane Bancel
Moderna, Inc. - CEO & Director
© -
Good. Thank you. So let me
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot